) were subjected to biochemical analysis and to detailed immunochemical analysis with rabbit anti-PEV immunoglobulins. The results of chemical analysis, of analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis performed in coajunction with silver staining, and of analysis by crossed immunoelectrophoresis, sodium dodecyl sulfate-polyacrylamide gel-crossed immunoelectrophoresis, and Western blotting showed clearly that lipopolysaccharide was a major constituent of each monovalent extract and that it was probably the dominant antigen present in at least 15 of the 16 monovalent extracts. A 16.2-kilodalton protein, which was pronase resistant and nonsedimentable at 105,000 x g and which appeared to be biochemically and antigenically unrelated to pili, was a common although minor antigen for all extracts. Several other proteins, some of outer membrane origin, were also detected in unformalinized extracts, but these were also minor antigenic constituents of the vaccine. Neither pilin nor flagellin appeared to be major protein constituents of tested monovalent extracts, although anti-flagella antibodies could be demonstrated in rabbit anti-PEV by Western blotting. Preliminary analysis by crossed immunoelectrophoresis of serum raised in volunteers to PEV also indicated the presence therein of antibodies to lipopolysaccharide antigens.
Pseudomonas aeruginosa is an opportunistic pathogen which is frequently associated with nosocomially acquired infections. Certain groups of patients, for example, those suffering from cystic fibrosis or those who are immunocompromised as a result of severe burn wounds, malignancy, or immunosuppressive therapy, appear to be particularly susceptible to infection by this organism (3) . Moreover, even with the availability of improved antibiotic therapy, the mortality rate of patients succumbing to infection by P. aeruginosa is still relatively high (see reference 9 for review). Immunotherapy is one promising method of treatment of patients at high risk to infection by P. aeruginosa. Therefore, in the past decade, much attention has been focused on the protective properties of the surface antigens of this bacterium and on the development of a safe and effective vaccine.
Lipopolysaccharide (LPS) has probably received the most attention as a protective surface antigen of P. aeruginosa. It has been clearly established that antibody directed against this outer membrane component protects mice against infection by homologous strains of P. aerluginosa (10, 11) . Anti-LPS antibody appears to be important also in the protection of humans against infection by this organism. High anti-LPS titers have been correlated with increased rates of survival among patients with pseudomonal bacteremia (50) , and in addition, during a 5-year clinical trial, the rate of Pseudomonas-related mortality among severely burned patients was found to be greatly reduced after immunization with a heptavalent LPS-based vaccine called Pseudogen (Parke, Davis & Co., Detroit, Mich. [1, 23] ). Severe adverse reactions to this vaccine, however, were common (1, 45) . The containing minimal medium supplemented where appropriate with [35S]methionine (1.4 to 1.7 1Ci/ml). For the preparation of some cellular components, bacteria were grown at 37°C in 500 ml of minimal medium (36) (44) .
Monovalent extracts and polyvalent vaccine PEV. The polyvalent vaccine PEV and its component monovalent extracts were prepared at Wellcome Biotechnology Ltd. as previously described (36) . Briefly, bacteria from 16 serotype strains were extracted at 3 x 1010 to 5 x 10'°viable organisms per ml in EDTA-glycine buffer at 37°C, and the cell-free supernatant fractions were sterilized by filtration and by the addition of Formalin to 0.3% (vol/vol). The polyvalent vaccine PEV was derived by pooling equal volumes of all 16 monovalent extracts (36) . The number ascribed to each monovalent extract denotes the IATS serotype of the strain from which the extract was prepared, with the exception that extract 14 is derived from IATS serotype 17. (IATS serotype 14 is rarely isolated and is not used in the production of PEV). For chemical analyses and analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis, PEV and the monovalent extracts were dialyzed against 10 mM Tris hydrochloride (pH 7.5) for 36 h at 4°C. Undialyzed extracts were used for analyses by crossed immunoelectrophoresis (CIE). The routine treatment of monovalent extracts with formaldehyde was omitted in experiments designed to assess the effect of this reagent on the resolution of constituent antigens. Preparation of LPS. LPS was extracted from whole lyophilized cells by the hot aqueous phenol procedure of Westphal and Jann (57) . After extensive dialysis against water, the aqueous phase was lyophilized and then suspended in 0.5 M NaCl to a final concentration of 0.75% (wt/vol). Nucleic acid was removed by fractional precipitation with cetyltrimethylammonium bromide (57) , and the detergent was eliminated by twice precipitating LPS from 0.5 M NaCl with 10 (42a, 55) . The method of precipitate excision and analysis used to determine the nature of protein antigens contained within radiolabeled CIE immunoprecipitates has been detailed elsewhere (42, 42a) .
SDS-polyacrylamide gel CIE was performed essentially as described by Chua and Blomberg (8) with the following modifications. In the first dimension, duplicate samples containing 75 ng of KDO were subjected to electrophoresis until the dye front reached 9.0 cm into the separating gel. Half of the polyacrylamide gel was then fixed and stained for carbohydrate (16) . The other half was washed three times in 200 ml of distilled water (3 times for 15 min each) and once in 200 ml of CIE running buffer (15 min) before excision of the individual lanes (width, 6 mm) for immunoelectrophoresis into antibody. In the second dimension, immunoelectrophoresis was performed on glass plates (106 by 80 by 2 mm) by using the Triton X-100 barbital buffer system routinely used for CIE (see above). Polyethylene glycol was omitted from the antibody gel, which contained 11.32 p.l of rabbit anti-PEV immunoglobulins per ml (1.9 mg of protein per ml). After electrophoresis at 4 V/cm for 16 to 18 h, gels were soaked for several hours in distilled water before pressing, washing, drying, and staining with Coomassie brilliant blue (42) .
SDS-polyacrylamide gel electrophoresis with 12.5% (wt/vol) polyacrylamide separating gels (32) and 15 protein molecular weight standards (43) and procedures for fluorography (4) and for silver staining for protein (41) and carbohydrates (16) were performed as described previously. Western blotting was done by the procedure of Burnette (5) with BA85 nitrocellulose membrane filters (pore size, 0.45 p.m; Schleicher & Schuell, Dassel, Federal Republic of Germany) and either standard-sized or mini gels (Marysol Ind. Co. Ltd., Tokyo, Japan). Peroxidase-conjugated goat anti-rabbit IgG (Miles Laboratories) was used as second antibody, and reacting antigens were visualized by incubating blots in freshly prepared solutions containing 18 ml of 50 mM Tris hydrochloride (pH 7.5), 2 ml of 0.6% (wt/vol) 4-chloro-1-napthol in methanol, and 10 p.l of 30% (100 volumes) H202.
Electron microscopy. Samples were negatively stained with 1% (wt/vol) potassium phosphotungstate (pH 7.0) and examined in a Hitachi HU-12A electron microscope.
Analytical procedures. Protein content was determined by a modified Lowry procedure (35) with bovine serum albumin as the standard. KDO was assayed by the thiobarbituric acid method after hydrolysis of samples in 0.1 N sulfuric acid for 30 min (30) . Carbohydrate was estimated by the phenolsulphuric acid procedure with a glucose standard (15) .
Nucleic acid was estimated from A2%0 by using an extinction coefficient (E260) for a 1-mg/ml solution of 50.8/cm (13) . (7, 34 ; see the legend to Fig. 5 ).
RESULTS
The protein profiles of all 16 monovalent extracts were also analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 1B) . A major protein with a molecular weight of 16, 200 was resolved for 15 of the 16 extracts. It could also be detected in the remaining extract (extract 7) at increased loadings of sample. At least half of the extracts also contained a second protein with a molecular weight of approximately 21,400, and most extracts contained several other minor proteins. From a consideration of protein-and carbohydrate-stained gels ( Fig. 1A and B) , neither the 16.2-nor the 21.4-kilodalton protein appeared to be glycosylated. A band located close to the dye front was also consistently stained by the protein silver staining procedure (Fig. 1B) .
VOL. 51, 1986 tion, flagella did not appear to be a major constituent of the extracts (Fig. 2, lanes 3, 4, and 7) , although anti-flagella antibody could be demonstrated in anti-PEV serum by Western blotting (see Fig. 11 ). Comparison of the polypeptide profiles of unformalinized extracts and isolated outer membrane fractions (Fig. 2, lanes 8 through 10) and studies of heat modifiability (not shown) suggested that some vaccine proteins, notably those with apparent molecular weights of 74,000, 46,000, and 24,500, were probably outer membrane in origin and that the 24,500-molecular-weight protein probably corresponded to protein G* described by Hancock and Carey (20) . Analyses of PEV and monovalent extracts by CIE. The antigenic compositions of PEV and all 16 monovalent extracts were analyzed by CIE. The standard pattern routinely obtained with the polyvalent vaccine, together with the number assigned to each resolved immunoprecipitate, is shown in Fig. 3 . Thus, 10 major antigens (no. 50 through 140) and 5 minor antigens (no. 10 through 41) were identified in PEV. Few additional antigens were detected by manipulation of the antibody concentration over an eightfold range, by using agarose of lower endoosmotic flow (-mr < 0.1) or by screening for cathodally migrating antigens (not shown). In contrast to PEV, the monovalent extracts had extremely simple CIE profiles, displaying, under standard conditions, only one or two immunoprecipitates (Fig. 4) . The immunoprecipitates formed by the major antigen in at least 10 of the extracts (extracts 1 through 3, 5 through 8, 10, 13, and 16) had similar overall morphologies in their possession of an anodal shoulder or double peak. After application of four to analyzed by CIE either alone (Fig. 4) or mixed with 13 Kl of PEV (B through F, respectively). Fig. 9B ). The profiles of CIE immunoprecipitates resolved for unformalinized extracts resembled those of the corresponding formalinized vaccine extract and were dominated by the same analogous major immunoprecipitin band (see Fig. 9A ).
The origins of major antigens in PEV were determined by coimmunoelectrophoresis of PEV with each individual extract. A few representative examples are shown in Fig. 5 , and the results for all 16 extracts are summarized in the legend to that figure. Thus, it was demonstrated that six of the extracts (extracts 1, 3, 5, 6, 10, and 13) each contributed to PEV an immunologically distinct antigen. In contrast, the major antigenic components derived from extracts 2 and 16 cross-reacted, as did those from extracts 7 and 8. Interestingly, the major antigen of extracts 2 and 16 not only cross-reacted with antigen no. 50 of PEV but also affected the height of the immunoprecipitate (no. 90) formed by extract 5 (Fig. 5) . This may indicate the existence of common determinants between these components. Antigen no. 130/140 was apparently derived from six different extracts, i.e., extracts 4, 9, 11, 12, 14, and 15. This immunoprecipitate, however, was heterogeneous in nature and difficult to resolve with clarity. Further analysis of pairs of these extracts by coimmunoelectrophoresis and immunodiffusion indicated, at best, reactions of only partial identity between their major antigens.
To ascertain whether a similar antibody response is elicited against PEV in humans, the polyvalent vaccine was analyzed by CIE with an intermediate gel containing human anti-PEV immunoglobulins. All of the major antigens precipitated by rabbit anti-PEV immunoglobulins also reacted to some extent with human immunoglobulins (Fig. 6 ).
Identification and properties of antigens resolved by CIE. The effect of protease, detergent, and heat treatment on the CIE profile of PEV is shown in Fig. 7 . Analysis indicated that antigens 50 through 120 were largely resistant to Streptomyces griseus protease (Fig. 7B) . The anodic shoulders of the immunoprecipitates did disappear after protease treatment, but this was paralleled by an increase in the peak heights of the main immunoprecipitin arcs and may reflect an association between the major antigens and some minor protease-sensitive vaccine component. In contrast, the antigen complex designated no. 130/140 was apparently affected by protease (Fig. 7B ). When Triton X-100 was omitted from the buffer system, individual immunoprecipitates were not resolved (Fig. 7C) sive boiling, they still retained their ability to bind antibody, although they evidently underwent some physical or chemical alteration which affected their electrophoretic mobilities in agarose (Fig. 7D) . Furthermore, this ability to bind antibody was unaffected by extended incubation (18 h at 20°C) of boiled samples with any one of three different proteases, viz., S. griseus protease, staphylococcal V8 protease, and trypsin (not shown).
As the properties of antigens 50 through 120 (viz., their serotype specificity [ Fig. 5 ] and heat and pronase resistance [ Fig. 7] ) are all reminiscent of LPS, the relationship between resolved antigens and LPS purified from selected serotypes was examined by CIE. LPS preparations from serotypes 1, 2, 5, 6, 8, 10, and 13 were each shown to contain a major antigenic component which shared immunological identity with antigens no. 110, 50, 90, 80, 100, 60, and 70, respectively (Fig. 8) . The anodic shoulders of the immunoprecipitates, however, were consistently less prominent for the LPS preparations than for the vaccine extracts. Outer membranes isolated from P. aeruginosa serotype 6 were also analyzed by CIE with rabbit anti-PEV immunoglobulins. One major antigen was precipitated, and this was also identified as LPS (not shown).
The identity of the minor antigen (no. 41) detected for all monovalent extracts at elevated loadings ( Fig. 9A and B) was established by the method of precipitate excision and analysis (42, 42a) . Thus, CIE analysis of unformalinized [35S]methionine-labeled extract 6, followed by excision of the relevant immunoprecipitate ( Fig. 9B and C) and analysis by SDS-polyacrylamide gel electrophoresis and fluorography (42, 42a) , identified a polypeptide with a molecular weight of 16,200 as the sole protein constituent of the antigen (Fig. 9D, lane 2) . Identical results were obtained for the corresponding antigen present in unformalinized [35S]methionine-labeled extract 12 (not shown). By the same procedures, two other minor antigens (x and y) present in extract 6 (Fig. 9B) were also identified. Antigen x contained a 42-kilodalton polypeptide (Fig. 9D, lane 3 sponding monovalent extract (panels B) with the same loadings of LPS and the following loadings of the monovalent extracts: 2, 2, 1.7, 1, 2.7, and 0.9 Jl, respectively. Individual monovalent extracts were run in parallel at identical loadings (data not shown; see Fig. 4 for general profiles). Loadings of monovalent extract were adjusted to give peak areas of 50 to 100% of those generated by the corresponding LPS serotype. The appearance, after coelectrophoresis (panels B), of single immunoprecipitates of increased area over that observed after CIE of LPS (panels A) thus establishes the identity of numbered antigens in PEV with LPSs of different serotypes. The panel number indicates the extract and, thus, the IATS serotype under investigation. Similar results (not shown) indicated that LPS purified from IATS serotype 13 corresponded to antigen no. 70 of extract 13 . The standard loading of rabbit anti-PEV immunoglobulin (4.72 ,ud/ml) was doubled in the case of serotype 6 which generated a somewhat fainter LPS immunoprecipitate (Fig. 4) . The anode is to the left and top of each immunoplate. the 16.2-kilodalton protein in this preparation being attributed to antigen entrapment (42, 42a) . Antigen y, which formed an incomplete immunoprecipitate, contained a single protein (probably protein G*) with a molecular weight of 24,500 (Fig. 9D, lanes 5 and 6) .
Analysis of monovalent extracts by SDS-polyacrylamide gel CIE. Antigens which retain or regain their antigenicity after SDS-polyacrylamide gel electrophoresis may be detected by electrophoresis in a second dimension into an antibodycontaining gel. By using this technique it was demonstrated that the rabbit anti-PEV serum contained high levels of antibody directed against the major carbohydrate component of each monovalent extract tested (viz., extracts 2, 4, 6, Fig. 10 . In e position and height of the immunoprecipitate precisely to that predicted from the position a the polyacrylamide gel of the bands of smooth polysaccharide in the case of extract 15). immunoprecipitate corresponding to rough LI the protein components could be detected emphasizing that these results demonstrate th (viz., extracts 4, 11, 14, and 15) of the si extracts which contributed to the ill-resolved precipitate no. 130/140 (Fig. 3) possessed LP charides which readily formed immunop agarose.
Analysis by Western blotting. Analysis of valents extracts by Western blotting with ra serum generated a profile almost identical to after silver staining of the extracts for carb 1A). For each serotype, by far the most domi could be attributed to heterogeneously sized L bands could be discerned among the intensel species (not shown). Since it was importestablish whether antibodies to other Pseudon were present, anti-PEV serum was exhaustively adsorbed 5 6 with LPS-6. The adsorbed serum was then used in Western blotting experiments to detect reactive antigens in several cellular fractions derived for IATS serotype 6 (Fig. 11) . Strong reactions were observed for flagella (Fig. 11, lane 6 (Fig. 11, lane _. -24-5 8) . Some of these may be related to flagella and to degradation products thereof. It is notable that reactions attributable to pili (Fig. 11, lane 7 (Fig. 2 and 11) (Fig. 1B) but was clearly distinguishable from PAO pilin by SDS-polyacrylamide gel electrophoresis (Fig.  2) . Third, as judged by immunoblotting, anti-PEV serum recognized the 16.2-kilodalton proteins but not PAO pilin (Fig. 11) . Conversely, antiserum raised to PAO pili reacted with PAO pilin but not with the 16.2-kilodalton proteins. In addition, the 16.2-kilodalton proteins were not recognized by antiserum raised to PAK pili.
The properties of this 16.2-kilodalton protein and also the 21.4-kilodalton polypeptide, viz., their presence in all or many of the serotypes, their ready removal from the cell surface by mild extraction or by homogenization, their apparent absence from purified outer membranes, their retention in supernatant fractions after centrifugation at 105,000 x g, and the apparent absence of sugar residues, may suggest a relationship with (the proteinaceous moiety of) the slime glyco(lipo) proteins which have been described for this organism (2, 14, 40, 54) . An alternative candidate is the so-called original endotoxin protein described by Tanamoto et al. (56) . This protein has a molecular weight of about 22,000 and is reported to be a common surface antigen for most serotypes of P. aeruginosa (9, 56) .
The antigenic and molecular composition of all 16 monovalent extracts appeared to remarkably simple, a phenomenon which can be attributed, at least in part, to the selective removal of a limited number of cell-surface antigens during extraction with EDTA-glycine buffer. This was not unexpected. Hedstrom et al. (25) found release of LPS and outer membrane proteins D, E, G, and Hi but not F, H2, or I on exposure of sucrose-stabilized P. aeruginosa to Tris-EDTA, and Hancock et al. (21) have documented the release of LPS and protein E under similar conditions. The proclivity of the organism to shed parts of its outer membrane is also underscored in a recent report documenting the spontaneous release of LPS during growth in defined medium (6) . However, the simplicity of the polypeptide profiles observed for this vaccine belie to some extent the complexity of the original monovalent extracts. Analyses of freshly prepared unformalinized extracts by SDS-polyacrylamide gel electrophoresis, CIE, and Western blotting clearly suggest the presence of outer membrane proteins and flagella within the original extracts. Although these do not seem to be major constituents of the vaccine, some, e.g., flagella and proteins F and H1/H2, appear capable of eliciting significant antibody responses (18, 24, 27) . As a consequence, the possible contribution of these components to the protection afforded by PEV should not be ignored.
Formalinization appeared to impair analysis of the extracts by causing aggregation of some of the protein components. Aggregation is slow, but it becomes a significant problem after a few months of storage at 4°C (unpublished observations). The As severe adverse reactions (including malaise, fever, and localized induration and pain) were observed after administration of another LPS-based Pseudomonas vaccine (1, 45) , it may appear remarkable that PEV-01 contains LPS as the major antigen but yet elicits few toxic side effects (52 
